Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1287)

  • Tellez, A; Ambrosioni, J; Hernandez-Meneses, M; Llopis, J; Ripa, M; Chambers, ST; Holland, D; Almela, M; Fernandez-Hidalgo, N; Almirante, B; Bouza, E; Strahilevitz, J; Hannan, MM; Harkness, J; Kanafani, ZA; Lalani, T; Lang, S; Raymond, N; Read, K; Vinogradova, T; Woods, CW; Wray, D; Moreno, A; Chu, VH; Miro, JM.

    Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci

    JOURNAL OF INFECTION. 2022; 85(2): 137-146 Nº de citas: 9 [doi:10.1016/j.jinf.2022.05.023]

  • Alvarez-Zaballos, S; Gonzalez-Ramallo, V; Quintana, E; Munoz, P; De la Villa-Martinez, S; Farinas, MC; Arnaiz-de las Revillas, F; de Alarcon, A; Rodriguez-Esteban, MA; Miro, JM; Goenaga, MA; Goikoetxea-Agirre, J; Garcia-Vazquez, E; Boix-Palop, L; Martinez-Selles, M.

    Multivalvular Endocarditis: A Rare Condition with Poor Prognosis

    Journal of Clinical Medicine. 2022; 11(16): Nº de citas: 22 [doi:10.3390/jcm11164736]

  • Mesquida, A; Diaz-Garcia, J; Sanchez-Carrillo, C; Martin-Rabadan, P; Alcala, L; Munoz, P; Escribano, P; Guinea, J.

    Delta F659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata

    CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(8): Nº de citas: 13 [doi:10.1016/j.cmi.2022.04.003]

  • Alcoceba, E; Gomez, A; Lara-Esbri, P; Oliver, A; Beltran, AF; Ayestaran, I; Munoz, P; Escribano, P; Guinea, J.

    Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain

    CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(8): 1113-1119 Nº de citas: 54 [doi:10.1016/j.cmi.2022.02.025]

  • Mejia-Chew, C; Carver, PL; Rutjanawech, S; Camargo, LFA; Fernandes, R; Belga, S; Daniels, SA; Muller, NJ; Burkhard, S; Theodoropoulos, NM; Postma, DF; van Duijn, PJ; Farinas, MC; Gonzalez-Rico, C; Hand, J; Lowe, A; Bodro, M; Vanino, E; Cruz, AF; Ramos, A; Makek, MJ; Mjahed, RB; Manuel, O; Kamar, N; Calvo-Cano, A; Carrasco, LR; Munoz, P; Rodriguez, S; Perez-Recio, S; Sabe, N; Alvarez, RR; Silva, JT; Mularoni, A; Vidal, E; Alonso-Titos, J; del Rosal, T; Classen, AY; Goss, CW; Agarwal, M; Lopez-Medrano, F.

    Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study

    CLINICAL INFECTIOUS DISEASES. 2022; 76(3): 995-1003 Nº de citas: 9 [doi:10.1093/cid/ciac608]

  • VAZQUEZ, E.; TARANCON, L.; CARRASCO, I.; VIGIL, S.; MUÑOZ-CHAPULÍ, M.; RINCON, E.; SAAVEDRA, J.; SANTOS, M.; AGUILERA, D.; HERNANZ, A.; SANTIAGO, B.; DE LEÓN, J.; Muñoz, Patricia; SANCHEZ, M.; NAVARRO, M.; MUÑOZ, M..

    SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns

    Frontiers in Immunology. 2022; 13: 947549 Nº de citas: 12 [doi:10.3389/fimmu.2022.947549]

  • Chakrabarti, A; Mohamed, N; Capparella, MR; Townsend, A; Sung, AH; Yura, R; Munoz, P.

    The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review

    Open Forum Infectious Diseases. 2022; 9(7): Nº de citas: 34 [doi:10.1093/ofid/ofac234]

  • Vallejo, M; Muniz, P; Kwon, M; Solan, L; Bailen, R; Carbonell, D; Chicano, M; Suarez-Gonzalez, J; Catalan, P; Bellon, JM; Trivino, JC; Dorado, N; Gallardo, D; Diez-Martin, JL; Ramirez, N; Martinez-Laperche, C; Buno, I.

    Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

    ANNALS OF HEMATOLOGY. 2022; 101(7): 1567-1576 Nº de citas: 11 [doi:10.1007/s00277-022-04841-8]

  • GIL, S.; CARBONELL, D.; PEREZ, V.; LOPEZ, R.; ALONSO, R.; MUÑOZ, P.; OCHANDO, JORDI; SÁNCHEZ-ARCILLA, I.; BELLON, J.; CORREA, R.; PION, M..

    Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines

    Biomedicines. 2022; 10(7): Nº de citas: 7 [doi:10.3390/biomedicines10071676]

  • Cano-Terriza, D; Beato-Benitez, A; Rodriguez-Sanchez, B; Agullo-Ros, I; Guerra, R; Jimenez-Martin, D; Barbero-Moyano, J; Garcia-Bocanegra, I.

    Outbreak of Yersinia pseudotuberculosis in capybaras (Hydrochoerus hydrochaeris) kept in captivity

    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 2022; 86: Nº de citas: 3 [doi:10.1016/j.cimid.2022.101811]

  • Perez-Rivera, JA; Arminanzas, C; Munoz, P; Kestler, M; Pinilla, B; Farinas, MC; Alvarez-Rodriguez, I; Cuervo, G; Rodriguez-Esteban, A; De Alarcon, A; Gutierrez-Villanueva, A; Pello-Lazaro, A; Selles, MM.

    Comorbidity and Prognosis in Octogenarians with Infective Endocarditis

    Journal of Clinical Medicine. 2022; 11(13): Nº de citas: 10 [doi:10.3390/jcm11133774]

  • Di Domenico, EG; Oliva, A; Guembe, M.

    The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections

    Microorganisms. 2022; 10(7): Nº de citas: 80 [doi:10.3390/microorganisms10071259]

  • Mesquida, A; Alvarez-Uria, A; Vicente, T; Munoz, P; Guinea, J; Escribano, P.

    Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study

    MEDICAL MYCOLOGY. 2022; 60(6): Nº de citas: 2 [doi:10.1093/mmy/myac040]

  • Benjumea, A; Diaz-Navarro, M; Hafian, R; Cercenado, E; Sanchez-Somolinos, M; Vaquero, J; Chana, F; Munoz, P; Guembe, M.

    Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci

    Frontiers in Microbiology. 2022; 13: Nº de citas: 12 [doi:10.3389/fmicb.2022.935646]

  • Munoz-Chimeno, M; Barturen, S; Garcia-Lugo, MA; Morago, L; Rodriguez, A; Galan, JC; Perez-Rivilla, A; Rodriguez, M; Millan, R; del Alamo, M; Alonso, R; Molina, L; Aguinaga, A; Avellon, A.

    Hepatitis E virus genotype 3 microbiological surveillance by the Spanish Reference Laboratory: geographic distribution and phylogenetic analysis of subtypes from 2009 to 2019

    Eurosurveillance. 2022; 27(23): Nº de citas: 23 [doi:10.2807/1560-7917.ES.2022.27.23.2100542]

  • Escribano, P; Perez-Granda, MJ; Alonso, R; Catalan, P; Alcala, L; Serra-Rexarch, JA; Osuna, L; Fernandez, A; Conti, A; Castellanos, A; Guinea, J; Muñoz P; Bouza, E.

    High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures

    Revista Espanola de Quimioterapia. 2022; 35(3): 288-292 Nº de citas: 6 [doi:10.37201/req/008.2022]

  • Olmedo, M; Kestler, M; Valerio, M; Padilla, B; Rodríguez González C; Chamarro E; Machado, M; Alvarez-Uria, A; Alcala, L; Muñoz P; Bouza, E.

    Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia. 2022; 35(3): 279-283 Nº de citas: 7 [doi:10.37201/req/120.2021]

  • Escribano, P; Sanchez-Pulido, AE; Gonzalez-Leiva, J; Valero-Lopez, I; Catalan, P; Munoz, P; Guinea, J; Adan, I; Adan, J; Alcala, L; Alonso, R; Alvarez-Uria, A; Bouza, E.

    Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(6): 865-870 Nº de citas: 7 [doi:10.1016/j.cmi.2022.02.014]